CTX-2026
CTX-2026 is a fully human antibody that binds to CD277. CTX-2026 shows an anti-tumor effect on ovarian tumor models. CTX-2026 can be used for the research of cancer[1].
Product Specifications
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ctx-2026.html
Purity
98.95
Solubility
10 mM in DMSO
Smiles
[3H][C][X2026]
Molecular Weight
(145.28 kDa)
References & Citations
[1]Payne KK, et al. BTN3A1 governs antitumor responses by coordinating αβ and γδ T cells. Science. 2020 Aug 21;369 (6506) :942-949.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY422338 100 µg
DEFB135 (NM_001033017) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNCB1658-500 1x 500 µL
P53 Tumor Suppressor Protein (DO-1), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741473-500 1x 500 µL
Prostate Specific Acid Phosphatase (PSAP) (PASE/4LJ), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details